View Item 

Show simple item record

Arterial/venous plasma nicotine concentrations following nicotine nasal spray
dc.contributor.authorMinoshima, Saroshien_US
dc.contributor.authorOhl, Lindaen_US
dc.contributor.authorZubieta, Jon-Karen_US
dc.contributor.authorKoeppe, Robert A.en_US
dc.contributor.authorDomino, Edward F.en_US
dc.contributor.authorGuthrie, Sally K.en_US
dc.date.accessioned2006-09-08T19:53:50Z
dc.date.available2006-09-08T19:53:50Z
dc.date.issued1999-11en_US
dc.identifier.citationGuthrie, S. K.; Zubieta, J. -K.; Ohl, L.; Koeppe, R. A.; Minoshima, S.; Domino, E. F.; (1999). "Arterial/venous plasma nicotine concentrations following nicotine nasal spray." European Journal of Clinical Pharmacology 55(9): 639-643. <http://hdl.handle.net/2027.42/42031>en_US
dc.identifier.issn0031-6970en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/42031
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10638392&dopt=citationen_US
dc.description.abstractBackground and objectives : Arterial (A) and venous (V) plasma nicotine and cotinine concentrations were measured after nasal nicotine spray in tobacco smokers of both genders. The hypothesis for this research was that a greater A/V difference in plasma nicotine would be present in males than females because males have greater skeletal muscle mass to bind nicotine.en_US
dc.format.extent112344 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; Springer-Verlag Berlin Heidelbergen_US
dc.subject.otherLegacyen_US
dc.subject.otherNasal Administrationen_US
dc.subject.otherCotinineen_US
dc.subject.otherKey Words Nicotineen_US
dc.titleArterial/venous plasma nicotine concentrations following nicotine nasal sprayen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry, The University of Michigan, Ann Arbor, MI, USA, US,en_US
dc.contributor.affiliationumDepartment of Psychiatry, The University of Michigan, Ann Arbor, MI, USA, US,en_US
dc.contributor.affiliationumDepartment of Pharmacology, The University of Michigan, 1150W. Medical Center Drive, Ann Arbor, MI 48109-0632, USA Tel.: +1-734-7649115; Fax: +1-734-7634450, US,en_US
dc.contributor.affiliationumMental Health Research Institute, The University of Michigan, Ann Arbor, MI, USA, US,en_US
dc.contributor.affiliationumDepartment of Nuclear Medicine Section of Internal Medicine, The University of Michigan, Ann Arbor, MI, USA, US,en_US
dc.contributor.affiliationumDepartment of Nuclear Medicine Section of Internal Medicine, The University of Michigan, Ann Arbor, MI, USA, US,en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid10638392en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/42031/1/228-55-9-639_90550639.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s002280050686en_US
dc.identifier.sourceEuropean Journal of Clinical Pharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
228-55-9-639_90550639.pdf
Size:
109.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.